Adjuvant Imatinib Mesylate After Resection of Localised, Primary Gastrointestinal Stromal Tumour: A Randomised, Double-Blind, Placebo-Controlled Trial
The Lancet - United Kingdom
doi 10.1016/s0140-6736(09)60500-6
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2009
Authors
Publisher
Elsevier BV